Evidence map

ArticleScientific reports2023

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR

Dawn Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36894641